Zentalis Pharmaceuticals Llc (ZNTL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $167.05M
Last updated: Nov 17, 2026 at 11:06 AM ET
Zentalis Pharmaceuticals Llc (ZNTL) Earnings: Report Dates and Results
Zentalis Pharmaceuticals Llc (ZNTL) is expected to report earnings on Mar 24, 2027. In the quarter ended Sep 30, 2026, Zentalis Pharmaceuticals Llc reported EPS of -$0.34, above the -$0.58 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ZNTL has an expected report date of Mar 24, 2027.
Earnings History
Of the 27 quarters below that had an estimate, ZNTL beat 12 and missed 15. The widest gap in the table came in the quarter ended Mar 31, 2020, when EPS landed 512.77% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.34 | -$0.58 | -$0.63 - -$0.42 | +41.38% | Beat | N/A | 8 | 2 up, 0 down | Nov 9, 2026 |
| Jun 30, 2026 | -$0.59 | -$0.45 | -$0.61 - -$0.30 | -31.11% | Miss | N/A | 8 | 0 up, 0 down | Aug 6, 2026 |
| Mar 31, 2026 | -$0.50 | -$0.47 | N/A | -7.43% | Miss | N/A | 3 | 0 up, 1 down | May 12, 2026 |
| Dec 31, 2025 | -$0.49 | -$0.61 | -$1.80 - -$0.25 | +19.67% | Beat | N/A | 7 | 3 up, 0 down | Mar 26, 2026 |
| Sep 30, 2025 | -$0.37 | -$0.48 | -$0.57 - -$0.38 | +22.92% | Beat | N/A | 7 | 5 up, 1 down | Nov 10, 2025 |
| Jun 30, 2025 | -$0.37 | -$0.52 | -$0.81 - -$0.43 | +28.85% | Beat | N/A | 7 | 4 up, 1 down | Aug 6, 2025 |
| Mar 31, 2025 | -$0.67 | -$0.61 | -$0.69 - -$0.52 | -9.84% | Miss | -578.6% | 7 | 0 up, 2 down | May 14, 2025 |
| Dec 31, 2024 | -$0.61 | -$0.68 | -$0.99 - -$0.47 | +9.96% | Beat | N/A | 10 | 4 up, 0 down | Mar 26, 2025 |
| Sep 30, 2024 | -$0.56 | -$0.87 | -$0.99 - -$0.81 | +35.63% | Beat | N/A | 9 | 0 up, 0 down | Nov 12, 2024 |
| Jun 30, 2024 | -$1.24 | -$0.83 | -$0.98 - -$0.47 | -49.40% | Miss | N/A | 11 | 0 up, 0 down | Aug 9, 2024 |
| Mar 31, 2024 | $0.14 | -$0.74 | -$0.96 - -$0.39 | +118.92% | Beat | N/A | 10 | 0 up, 0 down | May 7, 2024 |
| Dec 31, 2023 | -$0.93 | -$0.92 | -$1.54 - -$0.61 | -1.09% | Miss | N/A | 11 | 0 up, 0 down | Feb 27, 2024 |
| Sep 30, 2023 | -$0.79 | -$0.94 | -$1.24 - -$0.76 | +15.96% | Beat | N/A | 10 | 2 up, 0 down | Nov 6, 2023 |
| Jun 30, 2023 | -$1.85 | -$1.02 | -$1.15 - -$0.90 | -81.37% | Miss | N/A | 10 | 0 up, 0 down | Aug 9, 2023 |
| Mar 31, 2023 | -$1.07 | -$1.03 | -$1.44 - -$0.87 | -3.88% | Miss | N/A | 9 | 0 up, 0 down | May 10, 2023 |
| Dec 31, 2022 | -$0.92 | -$1.06 | -$1.67 - -$0.93 | +13.21% | Beat | N/A | 11 | 0 up, 0 down | Mar 1, 2023 |
| Sep 30, 2022 | -$0.96 | -$1.19 | -$1.41 - -$1.01 | +19.33% | Beat | N/A | 9 | 0 up, 0 down | Nov 9, 2022 |
| Jun 30, 2022 | -$1.34 | -$1.20 | -$1.32 - -$1.02 | -11.67% | Miss | N/A | 9 | 1 up, 0 down | Aug 9, 2022 |
| Mar 31, 2022 | -$1.31 | -$1.20 | -$1.39 - -$1.08 | -9.17% | Miss | N/A | 10 | 2 up, 0 down | May 5, 2022 |
| Dec 31, 2021 | -$1.11 | -$1.49 | -$1.59 - -$1.30 | +25.50% | Beat | N/A | 7 | 0 up, 0 down | Feb 24, 2022 |
| Sep 30, 2021 | -$0.09 | -$1.25 | -$1.43 - -$0.78 | +92.80% | Beat | N/A | 6 | 2 up, 0 down | Nov 10, 2021 |
| Jun 30, 2021 | -$1.34 | -$1.16 | -$1.34 - -$0.93 | -15.52% | Miss | N/A | 6 | N/A | Aug 12, 2021 |
| Mar 31, 2021 | -$1.24 | -$0.91 | -$1.06 - -$0.86 | -36.26% | Miss | N/A | 5 | N/A | May 17, 2021 |
| Dec 31, 2020 | -$1.01 | -$0.95 | -$1.16 - -$0.66 | -6.32% | Miss | N/A | 5 | N/A | Mar 25, 2021 |
| Sep 30, 2020 | -$0.91 | -$0.76 | N/A | -19.74% | Miss | N/A | 3 | N/A | Nov 9, 2020 |
| Jun 30, 2020 | -$0.78 | -$0.49 | -$0.58 - -$0.41 | -59.18% | Miss | N/A | 3 | N/A | Aug 13, 2020 |
| Mar 31, 2020 | -$2.88 | -$0.47 | -$0.96 - -$0.47 | -512.77% | Miss | N/A | 4 | N/A | Apr 6, 2020 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.90, after -$2.27 the year before. It was -$5.58 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.90 | N/A |
| Dec 31, 2024 | -$2.27 | N/A |
| Dec 31, 2023 | -$4.64 | N/A |
| Dec 31, 2022 | -$4.53 | N/A |
| Dec 31, 2021 | -$3.78 | N/A |
| Dec 31, 2020 | -$5.58 | N/A |
Frequently Asked Questions About ZNTL
When is Zentalis Pharmaceuticals Llc's next earnings date?
Zentalis Pharmaceuticals Llc's next earnings report is expected for Mar 24, 2027.
Did ZNTL beat earnings estimates last quarter?
Yes. Zentalis Pharmaceuticals Llc reported EPS of -$0.34 for the quarter ended Sep 30, 2026, above the -$0.58 estimate, a 41.38% surprise.
What EPS do analysts expect from ZNTL next quarter?
The consensus EPS estimate for Zentalis Pharmaceuticals Llc for the quarter ending Dec 31, 2026 is -$0.41 from 13 analysts, with estimates from -$0.59 to -$0.33.
How often does ZNTL beat earnings estimates?
Zentalis Pharmaceuticals Llc beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +9.30%.
ZNTL pages: Overview, Earnings, Forecast, Financials, Competitors